Drug Profile
Research programme: antifungals - CEPTYR
Alternative Names: BAP-100Latest Information Update: 09 Jul 2007
Price :
$50
*
At a glance
- Originator CEPTYR
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 12 Jul 2004 Preclinical trials in Mycoses in USA (unspecified route)